Table 1.
Summary of demographic and baseline characteristics by treatment group.
| LD PepGNP-Dengue (n = 10) |
LD vehicle-GNP (n = 3) |
HD PepGNP-Dengue (n = 10) |
HD vehicle-GNP (n = 3) |
All participants (n = 26) | |
|---|---|---|---|---|---|
| Sex | |||||
| Female | 4 (40%) | 2 (67%) | 5 (50%) | 1 (33%) | 12 (46%) |
| Male | 6 (60%) | 1 (33%) | 5 (50%) | 2 (67%) | 14 (54%) |
| Ethnicity | |||||
| Other | 1 (10%) | 0 (0%) | 1 (10%) | 1 (33%) | 3 (12%) |
| Caucasian | 9 (90%) | 3 (100%) | 9 (90%) | 2 (67%) | 23 (88%) |
| Age, years | |||||
| Mean | 30.9 (5.8) | 25.7 (1.5) | 28.5 (6.4) | 29.7 (6.1) | 29.2 (5.7) |
| Range | 23–40 | 24–27 | 20–43 | 23–35 | 20–43 |
| BMI, kg/m2 | |||||
| Mean | 25.3 (2.9) | 22.5 (2.0) | 23.5 (5.2) | 26.8 (6.8) | 24.5 (4.3) |
| Range | 22.0–31.2 | 20.5–24.5 | 18.4–35.6 | 21.2–34.3 | 18.4–35.6 |
| Current smokers | 3 (30%) | 0 (0%) | 4 (40%) | 0 (0%) | 7 (27%) |
Data are n (%) or mean (SD) unless stated otherwise.
BMI = body-mass index; LD = low dose; HD = high dose; GNP = gold nanoparticles.